The cellular geography of therapeutic resistance in cancer

Ended Cooperative Agreement Awarded Last action

Award ID
U2CCA233195
Recipient
Awarding agency
Obligated
$29,712,459

Award facts

Completion date
Originally
Funding
  • $24,789,859.40 Federal
  • $4,922,600.00 Non-federal
Place of performance
Boston, MA 02215, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment The cellular geography of therapeutic resistance in cancer - most patients who DIE from cancer do so because their cancer is resistant to available therapies,… -$158,789 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $1,241,085 $0
Amendment $1,241,085 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,524,826 $0
Amendment $2,524,826 $2,524,826
Amendment $2,524,826 $0
Amendment $2,524,826 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,397,774 $0
Amendment $2,397,774 $2,397,774
Amendment $0 $0
Amendment The cellular geography of therapeutic resistance in cancer - most patients who DIE from cancer do so because their cancer is resistant to available therapies,… $0 $0
Amendment $2,524,824 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,524,826 $0
Amendment $0 $0
Amendment $0 $0
Original award $2,521,976 $0
Show all 34

Subawards

Subrecipient Amount Awarded
The General Hospital Corporation Massachusetts General Hospital will coordinate the conduct of the clinical trials summarized in the proposal, consenting of patients for tumor biopsies and… $130,103
President And Fellows Of Harvard College We will perform multiplexed error-robust FISH (MERFISH) imaging of the colon, melanoma and breast tumor samples, identify the cell types, and map their… $177,535
J.david Gladstone Institutes Pl Engelhardt will be responsible for the computational and analytic methods development and application portion of the Data Analysis Unit (DAU). Pl… $130,412
The Broad Institute, Inc. The CASI TNP will support the development of computational methods for sample annotation and comparison, including (1) automated cluster annotation, (2)… $380,637

Quick answers

Who received award U2CCA233195?

U2CCA233195 was awarded to Dana-Farber Cancer Institute, Inc. by National Cancer Institute (National Institutes of Health) on September 24, 2018.

How much is award U2CCA233195 worth?

$29,712,459 has been obligated on U2CCA233195: $24,789,859 in federal funding and $4,922,600 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login